Kestra Medical Technologies, Ltd. (KMTS) Profit Margins
Over the twelve months to 2026-07-31, Kestra Medical Technologies, Ltd. (KMTS) had gross margin 53.9%, operating margin -134.5%, net margin -140.4%, free cash flow margin -115.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
KMTSKestra Medical Technologies, Ltd.Follow KMTS — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Dec, in 48 days
| Line | FY2024 Apr 24 | FY2025 Apr 25 | FY2026 Apr 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|
| Gross margin | 1.3% | 40.5% | 51.4% | 53.9% | |
| Operating margin | -305.8% | -177.8% | -141.6% | -134.5% | |
| Net margin | -338.4% | -190.3% | -138.4% | -140.4% | |
| FCF margin | -303.7% | -168.1% | -122.6% | -115.0% |
USD millions · SEC XBRL
Kestra Medical Technologies, Ltd. — questions
- What is Kestra Medical Technologies, Ltd.'s gross margin?
- 53.9% over the twelve months to 2026-07-31.
- What is Kestra Medical Technologies, Ltd.'s operating margin?
- -134.5% over the twelve months to 2026-07-31.
- What is Kestra Medical Technologies, Ltd.'s net profit margin?
- -140.4% over the twelve months to 2026-07-31.
Every figure on this page comes from Kestra Medical Technologies, Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.